A B S T R A C T Cholesterol esterification, cholesteryl ester transfer between lipoproteins, and cholesterol transport between lipoproteins and cultured cells have been measured in the plasma of 22 patients with primary hyperlipidemia and 10 normolipidemic subjects. In hyperbetalipoproteinemia, increase in plasma low density lipoprotein levels was associated with a reduction of cholesteryl ester transfer rates, and with a reversal of the normal direction of sterol transport between fibroblasts and their plasma culture medium. Instead of net transport from cells to medium there was a net uptake of sterol from plasma by the cells, despite a level of plasma lecithin/cholesterol acyltransferase activity that was within the normal range. In dysbetalipoproteinemia, esterification rates were increased above normal levels, but cholesteryl ester transfer was reduced and the direction of sterol transport between the cells and plasma medium was reversed, as in the hyperbetalipoproteinemic group. In hypertriglyceridemia, those subjects with cardiovascular disease showed a metabolic pattern similar to the hyperbetalipoproteinemic group. The subjects in this group without symptoms of cardiovascular disease showed a normal direction of sterol transport, normal or raised rates of cholesteryl ester transfer between lipoproteins, and an increased rate of sterol esterification in plasma that decreased towards normal levels as plasma triglyceride levels decreased. Despite their quite distinct metabolic patterns there was no consistent difference between the two hypertriglyceridemic groups in triglyceride or cholesterol levels, very low density lipoprotein composition, or electrophoretic or isoelectric focussing patterns. All hypertriglyceridemic Dr. P. Fielding
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INTRODUCTION
In normal human plasma, net transport of cholesterol from cells, cholesterol esterification by the lecithin/cholesterol acyltransferase (LCAT)' reaction, and the ability to transfer preformed cholesteryl esters to acceptor lipoproteins, influence the composition of plasma lipoproteins (1) (2) (3) . In human hyperlipidemia, the composition and concentrations of plasma lipoproteins are modified in ways that have been defined by biochemical studies. For example, in familial hypercholesterolemia both the concentration and cholesteryl ester content of low density lipoprotein (LDL) is increased (4) (5) ; in dysbetalipoproteinemia an increased concentration of intermediate density lipoproteins (IDL) of abnormal apoprotein composition has been demonstrated (6-7); and in hypertriglyceridemia the increased level of triglyceride in very low density lipoprotein (VLDL) is associated with changes in composition and concentration in LDL and high density lipoproteins (HDL) (8) (9) (10) (11) . However, the effects of altered lipoprotein composition on cholesterol metabolism in plasma have received much less atten-'Abbreviations used in this paper: apo, apoprotein; tion. In normal human plasma, LCAT and cholesteryl ester transfer activities can be envisaged as a part of a well-regulated sequence of reactions by which free cholesterol of cellular origin is converted to ester form and transported to lipoprotein particles (12) , LDL and VLDL mainly, from which it can be cleared by the liver (13) (14) (15) . The potential significance of this pathway can be seen from the effects of accumulation of free cholesterol that occurs in the plasma in LCAT deficiency (16) . It may also not be coincidental that it is especially the accumulation of the major acceptors of LCAT-derived cholesteryl esters in human hypercholesterolemia that appears to be strongly correlated with the development of atherosclerosis (17, 18) . It was the purpose of this research to evaluate the activities of the steps in this pathway in patients with well-defined forms of primary hyperlipidemia.
METHODS
The subjects who took part in this study were 22 patients with primary hyperlipidemia, and 10 healthy subjects matched to give a similar distribution of age and sex (Table  I ). The patient group was chosen to include individuals with one of the following characteristics: isolated elevation of LDL cholesterol concentration, dysbetalipoproteinemia documented by apoprotein (apo) E phenotype and VLDL cholesterol/triglyceride ratio, or hypertriglyceridemia without increased VLDL cholesterol/triglyceride ratio. Nephrosis was absent, thyroid function was normal, and there was no evidence of an immunoglobulin disorder. Blood was obtained from a brachial vein of subjects fasted overnight, mixed with one-twentieth volume of 0.2 M sodium citrate solution' (pH 7.5) , and centrifuged at 3VC (1,500 g, 30 min) to obtain plasma. The plasma was used immediately for the analytical procedures that are described in detail below.
Determination of cholesterol esterification rates. Plasma was diluted fivefold with ice-cold NaCl (0.15 M), brought to 0.01 M with Tris-HCl buffer (pH 7.4), and to 1 mM with disodium EDTA. Quintuplicate or sextuplicate 100-pu samples were taken by micropipette (Clay-Adams [Accufill], Div. of Becton, Dickenson & Co., Parsippany, NJ) into 0.9 ml of cold 0.15 M NaCl, then 1.0 ml of methanol and 1.0 ml of chloroform were added. Portions of the chloroform phase were taken for fluorimetric analysis (using the Farrand 135-800 spectrofluorimeter) of cholesterol and cholesteryl ester mass with cholesterol oxidase and'esterase (19) . The same number of samples was taken after 60 min of incubation at 370C. In some experiments, additional samples were taken at hourly intervals thereafter, for 2-3 h. The rate of esterification was determined as the rate of decrease in free sterol mass (2) from the linear portion of the plot (3) . Such decrease was inhibited 95% by 1.5 mM dithiobis(2-nitrobenzoic acid) (DTNB), an inhibitor of LCAT activity (20) .
Determination of cholesteryl ester transfer rates to VLDL and LDL. A major part of cholesteryl ester generated by the LCAT reaction in plasma is subsequently transferred by the activity of a specific transfer protein to VLDL and LDL (2-3). When LCAT is inhibited the rate of transfer is unchanged but in place of de novo synthesis, cholesteryl ester for transfer is derived from HDL (3). Cholesteryl ester transfer can therefore be assayed independently of LCAT activity as the rate of decrease in HDL cholesteryl ester in plasma where the LCAT activity has been inhibited by DTNB. As previously reported (3), for this purpose VLDL and LDL can be separated from HDL by precipitation with heparin and MnCl2 (21) . After addition of Tris-HCI and EDTA as described above for the cholesterol esterification assay, DTNB was added to ice-cold plasma to a final concentration of 1.5 mM and a portion (1.5 ml) was then mixed with a one-tenth volume of heparin-MnCl2 solution (heparin 104 IU/ml -1.0 M MnCI2). After centrifugation (15,000 g, 30 min at 3VC), quintuplicate samples of supernatant solution were taken for analysis of cholesteryl ester. A similar analysis was made at intervals during incubation at 370C as described for cholesterol esterification. The rate of decrease of supernatant cholesteryl ester, which was linear with time over the 60-min assay period, was then determined.
Determination of cholesterol net transport. The direction and velocity of transport was determined between cultured fibroblasts and plasma diluted in phosphate-buffered saline (PBS) (1) . Human preputial skin fibroblasts were cultured in 6-cm Falcon dishes (Falcon Labware, Div. of Becton, Dickenson & Co.). Cells were plated at an initial density of 6-8 X 104 cells per dish and cultured in Dulbecco's modified Eagle's medium containing 10% fetal calf serum. When the dishes contained 8-10 ,ug of sterol (about three-quarters confluence) the cells were washed with human serum albumin (4 mg/ml) (pH 7.4) in PBS (four times), with buffer (four times), and then incubated with the same medium containing diluted plasma from which fibrinogen had been removed by immunoaffinity chromatography (1) . Quintuplicate dishes of cells (and the same number of empty dishes) were filled with medium (3 ml) containing 1.5% (vol/vol) plasma in buffer medium. These conditions were chosen because in normocholesterolemic plasma they represent that midpoint of cell sterol transport at which -50% of the cholesterol demand for esterification via the LCAT reaction is derived from the cells (1). Fibrinogen-depleted plasma was diluted as required on the basis of protein determination with the Folin phenol reagent (22) . An initial 1-ml sample of medium was taken into methanol for analysis of free and esterified cholesterol mass (19) . The remaining 2 ml was incubated for 60 min at 37°C. A second 1-ml sample was taken for the same analysis. Quintuplicate dishes of cells that had been incubated with the plasma medium and the same number of unincubated dishes were washed as described above, and the cells were dissociated with 0.1 M NaOH and extracted with chloroform and methanol for analysis of free and esterified cholesterol. The rate of cholesteryl ester synthesis was unchanged by the presence or absence of cells, as previously described (1) (24) . The concentration of total cholesterol, unesterified cholesterol, phospholipids, and triglycerides in the VLDL (d < 1.006 g/ml), intermediate density lipoprotein (1.006 < d < 1.109 g/ml), LDL (1.019 < d < 1.063 g/ml), and HDL (d > 1.063 g/ml) fractions were calculated from the values for the infranatant and supernatant fractions. Total serum cholesterol and triglyceride levels were determined by an automated method (25) . The percentage of cholesterol present as esters was determined enzymatically (19) and phospholipids were determined from measurements of lipid phosphorus (26) . Electrophoresis of lipoprotein fractions in agarose gel was carried out by the method of Noble (27) , as modified by Pagnan et al. (28) . Isofocussing polyacrylamide gel electrophoresis of isoforms of apo E in VLDL was carried out on lipoprotein samples delipidated with ethanol and ether as previously described (29) .
Isolation of cholesteryl ester generating and acceptor fractions. VLDL and LDL acceptor lipoproteins were separated from plasma by precipitation with heparin and Mn+, as described above for transfer. The Table I . The seven patients with hyperbetalipoproteinemia had predominantly increased LDL cholesterol. In addition, five of them had cholesterol-enriched VLDL, with total cholesterol/triglyceride ratios ranging from 0.50 to 1.43, and the VLDL contained a distinct beta lipoprotein component. Four of these five patients and one of the two with ratios in the normal range fulfill criteria for the diagnosis of familial heterozygous hypercholesterolemia (30) . The five patients with dysbetalipoproteinemia all had cholesterol-rich VLDL with a beta lipoprotein component and an apo E-2/2 phenotype. By contrast, none of the nine hypertriglyceridemic patients had cholesterol-rich VLDL; three of those with atherosclerotic disease had two electrophoretic components in their VLDL but none had a beta lipoprotein component. In each of the three groups some patients had documented atherosclerotic disease of coronary or peripheral arteries. Within groups, no differences in lipoprotein-lipid distribution or in lipoprotein-lipid composition distinguished those patients who had documented atherosclerotic disease. In particular, in the hypertriglyceridemic group, there were no significant differences in the unesterified cholesterol/phospholipid or cholesteryl ester/triglyceride ratios in VLDL.
Cholesterol esterification in hyperlipidemic plasma. The rate of cholesterol esterification in plasma was determined in terms of the rate of decrease in plasma free cholesterol mass during incubation at 370C. As shown in Fig. 1 , rates in normocholesterolemic plasma were 17-52 jug sterol esterified ml-' plasma h-'. The mean rate was 32±10 jg sterol esterified ml-' plasma h-', comparable with that reported in a previous study of plasma from persons fasted overnight (31) . This rate was not significantly different from that found in the plasma of subjects with hyperbetalipoproteinemia (24±7 jg sterol esterified ml-' plasma h-') (mean±SD).
As shown in earlier studies and confirmed here ( Fig.  1 ), >90% of LCAT activity in normocholesterolemic plasma was removed by immunoaffinity chromatography on immobilized antibody to apo D (1), indicating the presence of a structural complex in plasma between these proteins. Similar results were obtained with hyperbetalipoproteinemic plasma (Fig. 1) ; the rate of loss of free cholesterol from plasma was reduced by a mean of 89% as compared with a reduction of 90% in the normocholesterolemic group.
In dysbetalipoproteinemic plasma, rates of cholesterol esterification (55±7 tig cholesterol esterified ml-' plasma h-') were significantly higher (P < 0.01) than in the control group ( Fig. 1 Table I ).
tivity (98 and 96% in the first and second subgroups, respectively) was removed by immobilized antibody to apo D, indicating retention of the complex even when esterification rates in plasma were elevated. As all measurements of LCAT activity were in terms of the decrease of free cholesterol mass, these findings indicate that the LCAT bound to apo D in plasma is functional in esterification, in each of the normo-and hyperlipidemic groups. In most of the hypertriglyceridemic patients (three of the first subgroup and five of the second) there were major (>50%) changes in the level of plasma triglyceride in the course of the study. The rates of cholesterol esterification at the highest and lowest triglyceride levels were compared. The mean high and low triglyceride levels were 1,950±537 and 446±366 mg/dl-1 in the subgroup with documented vascular disease and 1,570±807 and 550±312 mg/dl-1 in the subgroup without evidence of such disease. In the first subgroup there was no significant change in the esterification rate assayed at high and low triglyceride levels (33±1 vs. 32±6 Mg cholesterol esterified ml-' plasma h-1). In the second group, with high esterification rates at initial measurement, esterification rates at high and low triglyceride levels were 86.8±18.9 and 58.3±22.3 ug cholesterol esterified ml-' h-'. Thus even at the lowest triglyceride level, esterification rates were significantly higher than in the normolipidemic group (P < 0.05).
Cholesteryl ester transfer between lipoproteins in hyperlipidemic plasma. In normal plasma the major part of the cholesteryl ester synthesized by the LCAT reaction can be recovered in the VLDL and LDL fractions, which show the expected change in lipid composition during incubation in vitro (3). As shown in Fig. 2 Fig. 2 , affinity chromatography on immobilized antibody to apo D in both normo-and hyperlipidemic patients of all groups removed essentially the whole of plasma cholesteryl ester transfer activity. Averaging the data from all measurements, 98±12% of transfer activity was removed in this way, confirming the presence in plasma of a functional association between apo D and cholesteryl ester mass transfer to VLDL and LDL.
To further investigate the basis of the inhibition of cholesteryl ester transfer in the affected patient groups, plasma from these subjects was incubated with VLDL and LDL isolated from the plasma of subjects with normal transfer, either without fractionation or after removal of autologous VLDL and LDL by heparinSepharose affinity chromatography (Fig. 3) . As shown, cholesteryl ester transfer was significantly stimulated in dysbetalipoproteinemic plasma when the plasma was incubated with normal VLDL and LDL, and essentially normalized when endogeneous VLDL and LDL had been first removed. Similar results were obtained with representative plasma samples from patients with hyperbetalipoproteinemia, or with hypertriglyceridemia associated with reduced LCAT and transfer activities. On the other hand, the same reconstitution experiment in plasma from hypertriglyceridemics with normal transfer rates did not result in any augmentation of transfer. These results indicate that the block to transfer in hyperbetalipoproteinemic, dysbetalipoproteinemic, and certain hypertriglyceridemic subjects is the result not of a deficiency per se of the LCAT-transfer system, but of an inability of VLDL and LDL in the affected subjects to accept LCAT-derived cholesteryl ester. The greater transfer rate observed when endogeneous VLDL and LDL had first been removed from the plasma of the affected subjects by affinity chromatography, suggests that the abnormal VLDL and LDL inhibit the transfer of cholesteryl ester as well as being themselves ineffective acceptors. There was no difference in the extent to which cholesteryl ester transfer was stimulated in the same deficient plasma by the acceptor lipoproteins from normolipidemic plasma, or from the plasma of hypertriglyceridemic subjects with normal rates of cholesteryl ester transfer. There was also no difference in the stimulatory effect of VLDL and LDL, at the same concentration, isolated from plasma by heparinMnCl2 precipitation or by heparin-agarose affinity chromatography.
Cholesterol net transport between hyperlipidemic plasma and cultured cells. The direction and magnitude of cholesterol net transport between plasma and 454 P. E. Fielding, C. J. Fielding, R. J. Havel, J. P. Kane, and P. Tun cultured fibroblasts was determined with normal and hyperlipidemic plasma from the subjects shown in Table I . As shown in Fig. 4 , in the normal group, free cholesterol transport was in the direction of cells to medium, and its magnitude (0.44±0.04 ug h-') was quite similar to that reported earlier for nonfasted plasma (1). This rate is higher than that previously reported (0.26±0.03 gg h-'), probably on the basis of the use in the present study of less confluent cells. In one normocholesterolemic subject, whose triglyceride and cholesterol levels were maintained in a range of ±10% over a period of 12 mo, the net transport rate was 0.45±0.06 Mg h-1 (n = 6). Over the same period LCAT rates were 39.3±5.5 Mg cholesterol esterified ml-plasma h-'. There was a slight mean net uptake of cholesteryl esters from the medium to the cells (0.09±0.04 Mg h-1) (Fig. 4) . In all samples of hyperbetalipoproteinemic plasma there was a reversal of the normal direction of free cholesterol transport such that Mtg h-') ( Fig. 3) .
In the plasma of the hypertriglyceridemic patients, two quite distinct and nonoverlapping patterns were again evident. Classification within the subgroups was identical to that found for LCAT and cholesteryl ester transfer activities. In the subjects with documented cardiovascular'disease, the direction of net transport was reversed, as in the hyperbeta-and dysbetalipoproteinemic groups, and there was uptake (medium -p cells) of both free and esterified cholesterol (-0.98±0.48 and -0.93±0.43 Mg h-', respectively). In the subjects without apparent cardiovascular disease, the direction of cholesterol net transport was normal (cells -medium) and its magnitude (0.52±0.24) did not differ on the average from that of the normocholesterolemic group. In those subjects whose triglyceride levels changed (>50%) over the study period, there was no apparent consistent change in the rate of cholesterol transport. At high and low triglyceride levels cholesterol net transport was +0.48±0.21 and +0.55±0.12 Mg h-', respectively, in this group. Cholesteryl ester transport was +0.00±0.11 and +0.01±0.08 Mg h-' under these conditions. Balance studies were carried out to determine the content of cholesterol in cells and medium before and after incubation. In an experiment with hypertriglyceridemic plasma with reversed net cholesterol transport (Fig. 5) , loss of free and esterified cholesterol from the medium was associated with the expected increase in total cholesterol in the washed cells. However, recovery of cholesteryl ester, was only one-half of that predicted and that of free cholesterol was correspondingly greater, suggesting that hydrolysis of some of the cholesteryl ester derived from plasma had occurred within the 60-min incubation period. The intracellular metabolism of the interiorized cholesterol was further demonstrated by studies in which the incubation was continued for 5 h. Under these conditions, however, the whole increment of free and ester cholesterol was recovered in the esterified form.
Similgr results were obtained from balance studies with plasma samples representative of the other metabolic groups. In dysbetalipoproteinemic plasma (sub- Cell and medium sterol balance in cell-medium net transport of free and esterified cholesterol. Initial and final medium free and ester sterol contents were determined as described in the legend of Fig. 4 Values are mean±SD for quintuplicate dishes. Plasma was obtained from subject 16. medium was accompanied by an increase of 0.48 Mg of cholesterol in the washed cells after incubation. In a patient with hyperbetalipoproteinemia (subject 5) the corresponding mass changes were -0.78 and +0.62
Mg cholesterol, and in subject 21 with hypertriglyceridemia associated with a normal direction of cholesterol net transport, medium and cell cholesterol mass changes under the same conditions were +0.51 and -0.57 Mg cholesterol, respectively. To determine whether such transport depended on the high affinity endocytosis pathway, mutant fibroblasts lacking the LDL receptor were used in incubation and balance studies, and the results compared with those obtained with normal fibroblasts incubated simultaneously under identical conditions. As shown in Fig. 6 , there was no significant difference in the ability of normal and mutant fibroblasts to respond to plasma-derived cholesterol, indicating the independence of the processes described here from the LDL receptor mechanism. Similar experiments were carried out with plasma from hyperbetalipoproteinemic subjects in incubation with the receptor-deficient cells. Under conditions where cholesterol net transport was -0.65 Mg h-' with normal cells (subject 5), the corresponding cholesterol net transport with cells lacking the LDL receptor was -0.55 Itg h-'. The increments of cellular cholesterol mass measured in the same experiments were +0.45 and +0.42 ,g sterol. These results confirm that cholesterol transport in these experiments is at least in large part independent of the LDL receptor pathway.
Cholesterol efflux from labeled cells to normo-and hyperlipidemic plasma. The differences described above related to cholesterol net transport, i.e., the difference between efflux and influx rates between cells and medium. The rate of cholesterol efflux to normoand hyperlipidemic plasma was determined with [3Hjcholesterol-labeled fibroblasts under conditions identical to those used for determination of cholesterol net transport. There was no substantial difference in the ability of normo-and hyperlipidemic plasma to promote cholesterol efflux. Similar results were obtained from each of the different subject groups (Fig.  7) . This finding indicates that the difference in the direction of cholesterol net transport between these subject groups must result in large part from differing rates of influx to cells from plasma. Because influx is equivalent to (efflux -net transport), this difference FIGURE 6 Cell and medium balance in cell-medium net transport of free and esterified cholesterol using normal and LDL-receptor-deficient cultured fibroblasts. The experiments were carried out as described in the legend in Fig.  5 . Normal skin fibroblasts were as described in ref. 1 It is a major finding of this research that these relationships are substantially modified in three groups of hyperlipidemic human subjects at risk for atherosclerosis (hyperbetalipoproteinemics, dysbetalipoproteinemics, and hypertriglyceridemics with documented vascular disease [ Table II] ). In all the three groups, the normal direction of cholesterol net transport was reversed. In other words, when cells were incubated with medium containing plasma from these subjects, the spontaneous direction of cholesterol transport was not from cells to medium, as in normal metabolism, but from medium to cells, so that the cells accumulated cholesterol in spite of normal or nearly normal levels of cholesterol esterification in the plasma. Efflux was also normal from cells to such medium. Accordingly, the abnormality lies in the accelerated influx of cholesterol from plasma to cells, which overwhelms the normal regulatory mechanism, represented by the coupled activities of apo A-I-mediated efflux, and LCAT-mediated esterification (1, 2) .
The measurements reported in this study are of initial rates. With more prolonged incubation the ester- Fig. 3 , in each case such a reduced rate of cholesteryl ester transfer could be restored to essentially the rates characteristic of normolipidemic plasma by addition of acceptor lipoproteins (VLDL and LDL) from the plasma of individuals supporting normal transfer rates. This finding strongly supports the concept that in the affected patient groups, the inhibition of transfer that was observed was caused not by a defect of the LCATtransfer mechanism per se, but the inability of VLDL and LDL in hyperbetalipoproteinemia, dysbetalipoproteinemia, and hypertriglyceridemia associated with atherosclerotic vascular disease to accept LCAT-derived cholesteryl esters.
It is well established that cells can interiorize plasma lipoproteins as a unit by endocytosis via well-defined receptor sites (34) . Only one such system has been defined in fibroblasts, the B-E receptor interiorizing LDL and IDL. Several lines of evidence indicate that this pathway is not the one active in the cholesterol influx described here. Firstly, lipoprotein B-E receptors in cultured cells are normally highly down-regulated when exposed to plasma. Secondly, in cells with a genetic deficiency of the B-E receptor, the rate of influx from plasma was unchanged. Finally, free cholesterol, not esterified cholesterol, was the major lipid interiorized from hyperlipidemic plasma. In the hyperbetalipoproteinemic group there was on average no change in the transport of cholesteryl ester compared with the normal group, whereas free cholesterol transport was at a rate of -0.5 ,gg h-'. As this represents the difference between influx and an efflux rate of +0.5 ,g h-' under the same conditions, the mean influx rate of free cholesterol was 1.0 ,ug h-' in this group, relative to an influx of cholesterol as ester of 0.1 Mg h-1. In the dysbetalipoproteinemic group, calculated mean influx rate of free cholesterol (or efflux-net transport) was 1.5 Mg h-' and of ester cholesterol was 0.3 Mg h-1, whereas the corresponding values for the hypertriglyceridemic group with abnormal cholesterol transport, calculated in the same manner, were 1.3 and 1.0 Mg, respectively. These proportions do not correspond to the ratio between free and esterified cholesterol in any of the major plasma lipoprotein fractions, yet under the conditions described such transport represented 5-10% of the free sterol in the medium. Although further evidence is still needed, it appears at this point most likely that the movements of cholesterol from plasma to cells seen in this study represent lipid transfer from one or more plasma lipoprotein complexes, rather than the uptake of intact lipoprotein particles. Lipid transfer has been described from chylomicrons to endothelial cells (35) and from LDL to vascular smooth muscle cells and fibroblasts (36) . It is noteworthy that in each case such uptake was seen only in lipoproteins with increased cholesterol content and that uptake was via binding sites that had the kinetic properties of cell surface receptors. Similar mechanisms have been reported for HDL (37) .
Although the nature of the lipoprotein particle involved in the accelerated influx that is responsible for abnormal cholesterol transport is not at this point known, two major potential donors can be identified. Firstly, the data on cholesteryl ester transfer indicate that the VLDL and LDL populations in the abnormal plasma samples are poor acceptors for LCAT-derived cholesteryl ester. This may indicate an inhibition of transfer mediated by the cholesteryl ester content of these acceptors. All but two of the donors whose plasma supported abnormal cholesterol transport had a beta or slow pre-beta component of VLDL, which have been shown to represent cholesterol-enriched populations of VLDL (28) . However, there was no obvious difference in composition that differentiated the plasma of those hypertriglyceridemics whose plasma supported abnormal net cholesterol transport from those that did not. Secondly, an inhibition of cholesteryl ester transfer was associated with little if any decrease in the rate of ester synthesis. Indeed, in the case of the 458 P. E. Fielding, C. J. Fielding, R. J. Havel, J. P. Kane, and P. Tun dysbetalipoproteinemic group this rate was increased significantly above the normal rate. This finding indicates that in the plasma of those subjects with abnormal cholesterol transport, cholesteryl ester is being transferred at high rates to the HDL fraction of the plasma. It is therefore also possible that it is through an abnormal HDL particle that the abnormal cholesterol transport is mediated. Further research is needed to distinguish these alternatives. Our results demonstrate abnormal cholesterol transport between fibroblasts and plasma from patients with two genetic disorders associated with premature atherosclerotic disease, familial hypercholesterolemia, and familial dysbetalipoproteinemia. In addition, the same abnormality is present in some, but not all, patients with elevated VLDL levels and hypertriglyceridemia. Although patients with premature coronary heart disease are often found to be hypertriglyceridemic, several epidemiological studies have failed to show an independent association between plasma triglyceride levels and the incidence of coronary heart disease (38) . It is therefore of considerable interest that our hypertriglyceridemic patients who had abnormal cholesterol transport between cells and plasma all had documented atherosclerotic disease, whereas those with normal cholesterol transport did not. These preliminary observations are consistent with the hypothesis that the abnormality of cholesterol transport that we have demonstrated bears a causal relationship to atherogenesis in persons with various forms of hyperlipidemia. Whether a causal relationship exists or not, the cholesterol balance procedures described here may be of value in distinguishing among hypertriglyceridemic persons with and without clinically significant atherosclerotic disease.
Taken together, the results of this study support the concept that several groups at risk for atherosclerotic vascular disease, with diverse changes in concentration and composition of major lipoprotein fractions, share a common defect of plasma cholesterol metabolism. This defect involves an impedance of cholesteryl ester transfer to VLDL and LDL and the uptake of plasma cholesterol into cultured cells by a receptor-independent pathway.
